Lexi Ding
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Retinal Diseases and Treatments 12
- Glaucoma and retinal disorders 5
-
- Peroxisome Proliferator-Activated Receptors 8
- Angiogenesis and VEGF in Cancer 3
- RNA Research and Splicing 2
- Co-authors
- Jian‐xing Ma (9 shared papers)Rui Cheng (8 shared papers)Yusuke Takahashi (5 shared papers)Yang Hu (4 shared papers)Xuemin He (3 shared papers)Ying Chen (2 shared papers)Xiaobo Xia (3 shared papers)Elizabeth Pearsall (3 shared papers)
- Journals
- Frontiers in Endocrinology (5 papers)Investigative Ophthalmology & Visual Science (4 papers)Diabetes (2 papers)Biomedicine & Pharmacotherapy (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Lexi Ding
25 papers receiving 819 citations
Peers
Comparison fields: 5 of 65
- Ophthalmology 335
- Nephrology 63
- Molecular Biology 307
- Neurology 27
- Immunology and Allergy 17
Countries citing papers authored by Lexi Ding
This map shows the geographic impact of Lexi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lexi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lexi Ding more than expected).
Fields of papers citing papers by Lexi Ding
This network shows the impact of papers produced by Lexi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lexi Ding. The network helps show where Lexi Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Lexi Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 132 | |
| 2 | 2014 | 80 | |
| 3 | 2012 | 70 | |
| 4 | 2014 | 64 | |
| 5 | 2016 | 64 | |
| 6 | 2019 | 54 | |
| 7 | 2022 | 44 | |
| 8 | 2014 | 41 | |
| 9 | 2019 | 38 | |
| 10 | 2022 | 37 | |
| 11 | 2014 | 35 | |
| 12 | 2015 | 34 | |
| 13 | 2021 | 28 | |
| 14 | 2020 | 23 | |
| 15 | 2022 | 21 | |
| 16 | 2020 | 20 | |
| 17 | 2017 | 14 | |
| 18 | 2022 | 10 | |
| 19 | 2021 | 8 | |
| 20 | 2022 | 8 |
About Lexi Ding
Lexi Ding is a scholar working on Ophthalmology, Molecular Biology, Pharmaceutical Science, Nephrology and Immunology and Allergy, having authored 26 papers that have together received 836 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (12 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Glaucoma and retinal disorders (5 papers), Angiogenesis and VEGF in Cancer (3 papers), RNA Research and Splicing (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Advanced Drug Delivery Systems (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). The work is most often cited by research in Ophthalmology (335 citations), Nephrology (63 citations), Molecular Biology (307 citations), Neurology (27 citations) and Immunology and Allergy (17 citations). Lexi Ding has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jian‐xing Ma, Rui Cheng, Yusuke Takahashi, Yang Hu, Xuemin He, Ying Chen, Xiaobo Xia, Elizabeth Pearsall, Xiaobo Xia and Kyungwon Lee. Their work appears in journals such as Frontiers in Endocrinology, Investigative Ophthalmology & Visual Science, Diabetes, Biomedicine & Pharmacotherapy and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.